GLP-TZ is the name of the research product Tirzepatide, which is a dual GIP and GLP-1 receptor agonist from Zycare Peptides. The product comes lyophilized in reference quantities and is designed for scientists who investigate incretin physiology. In this blog we are going to find what is GLP-TZ, its applications, research and safety instructions for laboratory use.
Key Takeaways
• GLP-TZ refers to research-grade tirzepatide, which is a dual-acting drug on GIP and GLP-1 receptors; this product is for research purposes only.
• The dual action of tirzepatide on both GIP and GLP-1 receptors makes it more intensely investigated compared to single-target incretins such as semaglutide.
• HbA1c lowering effect ranges from 1.87% to 3.02%, while weight change ranges from 13 lbs to 28 lbs based on clinical studies.
What is GLP-TZ or Tirzepatide?
Tirzepatide is a synthetic peptide that stimulates both the receptors for GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) simultaneously. They are both “incretin” hormones that are secreted from the gastrointestinal tract upon food intake.
For most of the peptides in this class, like semaglutide, its mechanism primarily involves activation of one of these receptors. the GLP-1 receptor.
This is precisely why the researchers have taken more than half a decade to understand its mode of action on each receptor and why they continue to study it.
What the Clinical Research Shows on GLP-TZ (Tirzepatide)
Because tirzepatide is an FDA-approved medication under its brand names, it has gone through one of the most extensively documented trial programs of any recent metabolic drug.
Here is a brief table for you to know about GLP-TZ research done so far-
| Research Finding | Reported Result | Source |
| Glycemic control (SURPASS program, up to 104 weeks) | HbA1c reduced 1.87%–3.02% | PMC10088547 |
| Body weight change (Phase 3 trials) | -6.2 to -12.9 kg | PMC10231274 |
| Weight loss vs. single-target GLP-1 agonists | Tirzepatide exceeded comparators | PMC9494570 |
| Idiopathic intracranial hypertension, papilledema risk (2025 real-world study) | 68% relative risk reduction | PMC11825589 |
| Weight response in MC4R-mutation carriers (SURMOUNT-1) | Comparable to non-carriers at 72 weeks | PMC12532586 |
Benefits of using GLP-TZ
Glycemic Control
In the entire SURPASS study program, once-weekly tirzepatide achieved a lowering in glycosylated hemoglobin levels ranging from 1.87% to 3.02% over 104 weeks of treatment in patients with type 2 diabetes. The medication was also found to affect various cardiometabolic risk factors.
Outcomes involving weight
According to phase 3 trials, body weight was reduced by 13 to 28 lbs, in addition to lowering blood pressure and visceral fat – These findings demonstrated substantial effects on body weight and selected cardiometabolic measures.
Effect on weight compared to other treatments
In GLP-TZ 10 Mg studies that compare tirzepatide to conventional GLP-1 receptor agonists, it is noted that it results in more weight loss than single-target GLP-1 treatments, an effect attributed to its dual action.
Emerging areas of study on GLP-TZ
This is not where the scientific interest in the drug ends. GLP-TZ research is continuing in other areas of healthcare such as-
For idiopathic intracranial hypertension
A propensity-matched real-world study conducted in 2025 showed that the use of the drug results in a 68% decrease in the incidence of papilledema and almost a 74% decrease in the risk of developing visual disturbances in patients with idiopathic intracranial hypertension.
For genetic obesity
In addition to that, there have been investigations on its impact on patients suffering from rare genetic causes of obesity. There was no difference in weight loss for 72 weeks between patients with pathogenic mutations in the MC4R gene and those without them.
It is precisely because of this increasing multidirectional research interest that the Tirzepatide 10mg reference standard continues to be in high demand in university and commercial laboratories alike.
At Zycare Peptides, all batches of this compound are HPLC and MS tested to a minimum of 98% purity, and a certificate of analysis is provided for all batches.
Applications in Peptide Research
GLP-TZ is used exclusively as a reference standard in the lab, not as a final product. The purpose of GLP-TZ is simply to provide scientists with an already characterized version of tirzepatide.
Receptor binding and signaling
Due to its nature as a GIP- and GLP-1-biased agonist, it is a good candidate for use as a probe for understanding structure-receptor interactions and signaling.
Comparative incretin studies
Researchers working on incretins usually test tirzepatide against single-target GLP-1 analogs to assess its impact on its own.
GLP-TZ and metabolic pathway modeling
Since GLP-TZ peptide research is known for its glucose-dependent insulin secretion and appetite signaling functions, it can help in modeling metabolic pathways related to energy and glucose homeostasis.
Analysis and Formulation Studies
Certain laboratories employ reference-grade tirzepatide as a starting point for method development, including optimizing HPLC or MS methods to identify and quantify incretin peptides.
Who Uses Research-Grade Tirzepatide
GLP-TZ is meant to be used by researchers and institutes in conducting lab experiments and is definitely not a product meant for the end user. The target market for a product of this sort seems to be quite specialized indeed.
Research institutes
Research institutes carrying out academic research on GLP-TZ mechanism on metabolic hormone signaling, receptor pharmacology, or incretin biology.
Contract research organizations (CROs) that carry out preclinical testing and assay development for pharmaceutical/biotech companies.
R&D teams in biotech and pharma companies
Comparative evaluation of new incretin agents with respect to a known dual agonist with a large literature database behind it.
Analytical QC laboratories
Laboratories engaged in the analytical development or validation of detection methods for tirzepatide and its analogues.
Safety Considerations for Research Use
GLP-TZ is a laboratory reference substance and not a consumer product, and thus the term safety used here relates to safety while handling the substance in a laboratory environment, and not dosing information for personal consumption, which this article does not provide.
Personal protective equipment
Standard PPE for lab work includes wearing gloves, eye protection, and a lab coat while working with any peptide compound.
Aseptic technique
The reconstitution and handling should adhere to proper sterile laboratory techniques in order to avoid contaminating the sample, thus preserving the purity of the compound and the validity of data obtained from it.
Proven purity minimizes risks
Using an impure compound means bringing unaccounted-for variables into an experiment. In a laboratory environment, unknown impurities represent an additional risk of handling. This is the reason why Zycare Peptides offers an HPLC/MS-verified COA with every GLP-TZ batch.
Stability and storage for GLP-TZ
The drug is unstable when exposed to high temperatures, light, and repeated freeze/thaw processes. Unopened lyophilized vials of Tirzepatide should be kept in cold storage between 2-8°C for immediate use and -20°C for long-term storage, away from any light source. Do not freeze the reconstituted drug or repeatedly cycle the temperature once the vial is open, as an unstable vial cannot be used scientifically or safely.
Why Researchers Choose Zycare Peptides for GLP-TZ
There are a few characteristics that distinguish a good research source from an average one.
Proven purity of each batch
The COA and lab test results are posted along with the product description and are not made available only upon request.
Shipping across the USA
Orders are shipped within 24-48 hours and delivered within 3-4 days – important for time-sensitive studies.
A team of researchers for thorough batch testing
The team is trained in peptide chemistry and is not a general customer service team to assist researchers with their technical queries. You can easily contact the team at Zycare’s contact us page.
Consistent supply across any order size
Availability of supply throughout the process, regardless of the quantity ordered, be it one vial or a batch, especially if it is a lengthy protocol conducted in a lab.
Conclusion
The dual receptor activity of tirzepatide has made it one of the most extensively investigated incretin hormones in the past decade. The clinical research history of this hormone involves glycemic control, weight management, and several other conditions that are currently under scientific investigation.
For those who demand high-purity tirzepatide accompanied by the appropriate paperwork regarding its purity, these facilities will also have to take into account considerations relating to the source of the product.
Zycare Peptides provides GLP-TZ with third-party purity verification and a COA for each lot produced; this level of transparency is what makes the product trustworthy.
Frequently Asked Questions
What is GLP-TZ?
GLP-TZ is the laboratory-grade tirzepatide reference compound offered by Zycare Peptides. This substance is provided as lyophilized peptides and is intended to be used for laboratory studies of metabolic and endocrine signaling pathways and is not for sale for humans.
What does tirzepatide do to the body?
The main function of tirzepatide is to activate both GIP and GLP-1 receptors. Studies have found that it selectively binds to the GIP receptor and acts in a biased way on the GLP-1 receptor.
Is tirzepatide FDA-approved?
Yes, in its role as a prescription drug under certain brand names and for approved uses via the SURPASS and SURMOUNT clinical trials. GLP-TZ, the study drug that is the subject of this document, is a laboratory standard substance that has no bearing on any FDA-approved medication.
Tirzepatide: What Have Clinical Trials Shown?
Studies show that tirzepatide produces decreases in HbA1c levels of 1.87-3.02% as well as a decrease in body weight of 6-13 kg. The clinical significance of this compound has also been evaluated in other diseases, such as idiopathic intracranial hypertension.
Who usually buys tirzepatide for research?
Researchers who work in academic laboratories, contract research organizations, biotech researchers, and analytical laboratories who require an authenticated reference compound for their metabolic and receptor pharmacology studies.
How should GLP-TZ be stored?
Being a lyophilized peptide, GLP-TZ should be stored refrigerated at 2-8°C for short-term or frozen (-20°C) for long-term, away from light.
Why is the purity test important for a research peptide?
Contaminants or a deteriorated peptide may lead to skewed results and poor reproducibility in binding tests. At least HPLC/MS confirmed purity with a published COA is the minimum standard expected of any peptide used in research.
